Overview
Mitochondrial myopathies are a diverse group of genetic disorders caused by mutations in the mitochondrial DNA (mtDNA). These disorders primarily affect the muscles, but they can also impact other organs and systems in the body. Mitochondrial myopathies are characterized by a range of symptoms, including muscle weakness, fatigue, exercise intolerance, and other systemic manifestations. The disorders are often inherited in a maternal lineage, as only egg cells contribute mitochondria to the developing embryo.Mitochondrial myopathies are a result of dysfunctional mitochondria, which are the energy-producing structures within cells. Mitochondria are responsible for generating energy in the form of ATP (adenosine triphosphate) through a process called oxidative phosphorylation. In mitochondrial myopathies, the mutations in mtDNA disrupt this process, leading to a decrease in energy production and an accumulation of toxic byproducts. This can cause damage to the muscles and other tissues, resulting in a range of symptoms.
History/Background
The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and other systemic symptoms. However, it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of mtDNA mutations as the cause of mitochondrial myopathies revolutionized the field of genetics and paved the way for the development of new diagnostic and therapeutic strategies.Key Information
Mitochondrial myopathies are caused by mutations in the mtDNA, which is inherited from the mother. There are over 150 known mtDNA mutations associated with mitochondrial myopathies, each with its unique set of symptoms and characteristics. The disorders can be classified into several categories, including:* Kearns-Sayre syndrome: a rare disorder characterized by muscle weakness, eye abnormalities, and cardiac conduction defects.
* Myoclonic epilepsy with ragged-red fibers (MERRF): a disorder characterized by muscle weakness, seizures, and other systemic symptoms.
* Neuropathy, ataxia, and retinitis pigmentosa (NARP): a disorder characterized by muscle weakness, ataxia, and vision loss.
